* La'akari da abubuwan da suka hada da ci gaban cutar, karuwar matakan rigakafi, da gogewar rigakafin annoba, kasar Sin ta shiga wani sabon mataki na mayar da martani na COVID.
* Babban abin da aka fi mayar da hankali kan sabon matakin mayar da martani na COVID-19 na kasar Sin shi ne kare lafiyar mutane da hana kamuwa da cutar.
* Ta hanyar inganta matakan rigakafi da sarrafawa, kasar Sin tana kara kuzari a cikin tattalin arzikinta.
BEIJING, Janairu 8 - Daga ranar Lahadi, kasar Sin ta fara sarrafa COVID-19 tare da matakan da aka tsara don yakar cututtuka masu yaduwa na Class B, maimakon cututtukan Class A.
A cikin 'yan watannin nan, kasar ta yi gyare-gyare da yawa a cikin martanin COVID-19, daga matakan 20 a watan Nuwamba, sabbin matakai 10 a cikin Disamba, suna canza kalmar Sinanci na COVID-19 daga "novel coronavirus pneumonia" zuwa "cututtukan coronavirus labari. ” da kuma rage darajar matakan sarrafa COVID-19.
Yayin da ake fuskantar rashin tabbas game da annobar cutar, kasar Sin ta kasance tana sanya rayuwar jama'a da lafiyar jama'a a gaba, tare da daidaita martaninta na COVID bisa la'akari da yanayin da ake ciki.Waɗannan ƙoƙarin sun sayi lokaci mai mahimmanci don sauyi mai sauƙi a cikin martanin COVID.
YANKE HUKUNCIN KIMIYYA
Shekarar 2022 ta ga saurin yaduwar bambance-bambancen Omicron mai saurin yaduwa.
Siffofin cutar da ke saurin canzawa da sarkakkiya na mayar da martani game da barkewar annoba sun haifar da babban kalubale ga masu yanke shawara na kasar Sin, wadanda suka sa ido sosai kan yanayin annobar tare da sanya rayuwar jama'a da lafiyar jama'a a gaba.
An ba da sanarwar matakan daidaitawa 20 a farkon Nuwamba 2022. Sun haɗa da ma'aunin don daidaita nau'ikan wuraren haɗarin COVID-19 daga babba, matsakaici, da ƙasa, zuwa babba da ƙasa kawai, don rage adadin mutanen da ke ƙarƙashin keɓe ko kuma bukatar kula da lafiya.Hakanan an soke tsarin hana zirga-zirgar jirage masu shigowa.
An yi gyare-gyaren ne bisa kididdigar kimiyya na Omicron bambance-bambancen da ke nuna cewa kwayar cutar ta ragu sosai, da kuma tsadar rayuwar jama'a na ci gaba da shawo kan annobar da ta karu cikin sauri.
A halin da ake ciki, an aike da dakarun da ke aiki a duk fadin kasar don sa ido kan yadda annobar cutar ta bulla da kuma tantance al'amuran cikin gida, kuma an gudanar da tarurruka don neman shawarwari daga manyan kwararrun likitoci da ma'aikatan dakile yaduwar cutar.
A ranar 7 ga watan Disamba, kasar Sin ta fitar da dasawar ci gaba da inganta martaninta na COVID-19, inda ta sanar da sabbin matakan rigakafi guda 10 don sassauta takunkumi kan ziyartar wuraren taruwar jama'a da tafiye-tafiye, da rage iyaka da yawan gwajin gwajin sinadarin nucleic acid.
Babban taron kolin tattalin arziki na shekara-shekara da aka gudanar a birnin Beijing a tsakiyar watan Disamba, ya bukaci a yi kokarin inganta matakan dakile yaduwar cutar bisa la'akari da yanayin da ake ciki tare da mai da hankali kan tsofaffi da masu fama da cututtuka.
A karkashin irin wannan ka'idojin jagora, an tattara bangarori daban-daban na kasar, tun daga asibitoci zuwa masana'antu, don tallafawa ci gaba da daidaita matakan dakile yaduwar cutar.
Yin la'akari da abubuwan da suka haɗa da haɓakar cutar, haɓakar matakan rigakafi, da ƙwarewar rigakafin annoba, ƙasar ta shiga wani sabon yanayin martanin COVID.
Dangane da irin wannan yanayin, a ƙarshen Disamba, Hukumar Lafiya ta ƙasa (NHC) ta ba da sanarwar rage tsarin sarrafa COVID-19 tare da cire shi daga kula da cututtukan da ke buƙatar keɓe kai daga ranar 8 ga Janairu, 2023.
Liang Wannian, shugaban COVID- ya ce "Lokacin da cutar ta haifar da rashin lahani ga lafiyar mutane kuma ta bar tasiri mai sauƙi kan tattalin arziki da al'umma, yanke shawara ce ta kimiyya don daidaita girman matakan rigakafi da sarrafawa," in ji Liang Wannian, shugaban COVID- Kwamitin ƙwararrun martani na 19 a ƙarƙashin NHC.
GASKIYAR KIMIYYA, AKAN LOKACI DA WAJIBI
Bayan yaƙar Omicron kusan shekara guda, China ta sami cikakkiyar fahimta game da wannan bambance-bambancen.
Jiyya da ƙwarewar sarrafa bambance-bambancen a cikin biranen kasar Sin da yawa da kuma ƙasashen waje sun nuna cewa yawancin marasa lafiya da suka kamu da cutar ta Omicron ba su nuna ko dai ba alamun cututtuka ko kuma alamu masu sauƙi - tare da ƙaramin adadin da ke haɓaka cikin yanayi mai tsanani.
Idan aka kwatanta da nau'in asali da sauran bambance-bambancen, nau'ikan Omicron suna zama mafi sauƙi dangane da cututtukan ƙwayoyin cuta, kuma tasirin ƙwayar cuta yana canzawa zuwa wani abu kamar cututtukan cututtukan yanayi na yanayi.
Ci gaba da nazarin ci gaban kwayar cutar ya kasance wani muhimmin sharadi ga kasar Sin wajen inganta ka'idojin sarrafa kanta, amma ba shi kadai ba ne dalili.
Don kare rayukan jama'a da lafiyar jama'a zuwa ga mafi girma, kasar Sin ta sa ido sosai kan barazanar kamuwa da cutar, matakin rigakafi na jama'a da karfin tsarin kiwon lafiya, da kuma matakan shiga tsakani a fannin kiwon lafiyar jama'a.
An yi kokari ta kowane bangare.Ya zuwa farkon watan Nuwamba 2022, sama da kashi 90 na al'ummar kasar an yi musu cikakkiyar rigakafin.A halin yanzu, ƙasar ta sauƙaƙe haɓakar magunguna ta hanyoyi daban-daban, tare da shigar da magunguna da magunguna da yawa a cikin ka'idojin gano cutar da magani.
Hakanan ana amfani da karfi na musamman na magungunan gargajiya na kasar Sin don hana kamuwa da cuta mai tsanani.
Bugu da kari, ana samar da wasu magunguna da yawa da ke niyya kamuwa da cutar COVID, wanda ke rufe dukkan hanyoyin fasaha guda uku, gami da toshe shigar kwayar cuta cikin sel, hana kwafin kwayar cutar, da daidaita tsarin garkuwar jiki.
MANUFOFIN COVID-19 AMSA
Babban abin da aka fi mayar da hankali kan sabon matakin mayar da martani na COVID-19 na kasar Sin shi ne kare lafiyar jama'a da hana kamuwa da cuta mai tsanani.
Tsofaffi, mata masu juna biyu, yara, da marasa lafiya da ke fama da na yau da kullun, cututtukan da ke cikin ƙasa ƙungiyoyi ne masu rauni a fuskar COVID-19.
An kara kaimi don saukaka yiwa tsofaffi rigakafin cutar.An inganta ayyuka.A wasu yankuna, tsofaffi na iya sa likitoci su ziyarci gidajensu don gudanar da alluran rigakafin.
A cikin kokarin da kasar Sin ke yi na inganta shirye-shiryenta, hukumomi sun bukaci asibitoci na matakai daban daban da su tabbatar da cewa an samu asibitocin zazzabi ga mabukata.
Ya zuwa ranar 25 ga Disamba, 2022, akwai sama da asibitocin zazzabin 16,000 a asibitoci a matakin digiri na biyu ko sama da haka a fadin kasar, da kuma asibitocin zazzabi sama da 41,000 ko dakunan tuntuba a cibiyoyin kiwon lafiya na al'umma.
A gundumar Xicheng da ke tsakiyar birnin Beijing, an bude wani asibitin zazzabin cizon sauro a dakin motsa jiki na Guang'an a ranar 14 ga Disamba, 2022.
Tun daga ranar 22 ga watan Disamba, 2022, da yawa daga cikin wuraren da aka yi amfani da su a gefen titi, wadanda tun da farko ake amfani da su a matsayin wani bangare na aikin gwajin sinadarin acid, an mai da su zuwa dakunan tuntubar zazzabi na wucin gadi a gundumar Xiaodian da ke birnin Taiyuan na arewacin kasar Sin.Wadannan dakunan zazzabi suna ba da sabis na tuntuba da rarraba masu rage zazzabi kyauta.
Daga hada kayan aikin likitanci zuwa kara karfin asibitoci don karbar masu fama da munanan lokuta, asibitoci a duk fadin kasar na ci gaba da gudanar da ayyukansu cikin sauri tare da ba da karin albarkatu don kula da munanan lokuta.
Bayanai na hukuma sun nuna cewa ya zuwa ranar 25 ga Disamba, 2022, akwai jimillar gadaje masu kulawa 181,000 a kasar Sin, wanda ya karu da kashi 31,000 ko kashi 20.67 idan aka kwatanta da ranar 13 ga Disamba.
An yi amfani da hanya mai fa'ida da yawa don biyan bukatun mutane na kwayoyi.Haɓaka nazarin samfuran likitanci da ake buƙata, Hukumar Kula da Kayayyakin Kiwon Lafiya ta ƙasa, tun daga ranar 20 ga Disamba, 2022, ta ba da izinin tallatawa ga magunguna 11 don maganin COVID-19.
A lokaci guda, mazauna birane da yawa sun ɗauki ayyukan sa kai na al'umma don taimakawa juna ta hanyar raba kayan aikin likita, gami da na'urorin auna zafin jiki da magungunan kashe qwari.
KYAUTA GASKIYA
Sarrafa COVID-19 tare da matakan yaƙi da cututtukan Class B aiki ne mai rikitarwa ga ƙasar.
An fara gudanar da balaguron balaguro na kwanaki 40 na bikin bazara tun a ranar 7 ga watan Janairu, lamarin da ya haifar da babban gwaji ga yankunan karkarar kasar, yayin da miliyoyin mutane za su koma gida domin hutu.
An fitar da jagorori domin tabbatar da samar da magunguna, da kula da masu fama da munanan cututtuka, da kare tsofaffi da yara a yankunan karkara.
Misali, an kafa kananan tawaga 245 a gundumar Anping da ke lardin Hebei da ke arewacin kasar Sin don ziyarar jinya ga iyalai, wadanda suka hada da kauyuka 230 da al'ummomi 15 na lardin.
A ranar Asabar, kasar Sin ta fitar da bugu na 10 na ka'idojin sarrafa COVID-19 - wanda ke nuna allurar rigakafi da kariya ta mutum.
Ta hanyar inganta matakan rigakafi da sarrafawa, kasar Sin tana kara kuzari a cikin tattalin arzikinta.
An kiyasta GDP na shekarar 2022 ya zarce yuan tiriliyan 120 (kimanin dalar Amurka tiriliyan 17.52).Tushen don juriyar tattalin arziki, yuwuwar, kuzari, da haɓaka na dogon lokaci ba su canza ba.
Tun bayan barkewar COVID-19, kasar Sin ta yi fama da bala'in kamuwa da cuta kuma ta yi nasarar rike kanta a lokutan da sabon labari coronavirus ya yi kamari.Ko a lokacin da kididdigar ci gaban bil Adama ta duniya ta ragu na tsawon shekaru biyu a jere, kasar Sin ta haura matsayi shida a kan wannan kididdigar.
A farkon farkon shekarar 2023, tare da matakan mayar da martani na COVID-19 mai ƙarfi, buƙatun cikin gida ya ƙaru, an haɓaka amfani da shi, kuma ana ci gaba da samarwa cikin sauri, yayin da masana'antun sabis na mabukaci suka murmure kuma guguwar rayuwar mutane ta dawo cikin sauri.
Kamar dai yadda shugaba Xi Jinping ya ce a cikin jawabinsa na sabuwar shekara ta 2023: “Yanzu mun shiga wani sabon mataki na mayar da martani ga COVID inda har yanzu akwai kalubale masu tsanani.Kowa yana riƙe da ƙarfi sosai, kuma hasken bege yana gabanmu.”
Lokacin aikawa: Janairu-09-2023